Home › Funds › EDGAR LOMAX CO/VA › JNJ

EDGAR LOMAX CO/VA position in JNJ

JOHNSON & JOHNSON · Health Care

EDGAR LOMAX CO/VA reported holding 124,530 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$33.0M, representing 2.49% of its reported portfolio and ranking #15 among its reported holdings. EDGAR LOMAX CO/VA has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)124.53K sh
Reported value held$32.97M
Portfolio Weight2.49%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How EDGAR LOMAX CO/VA's JNJ position evolved

EDGAR LOMAX CO/VA first disclosed a stake in JNJ in Q3 2023 at 102,287 shares (US$15.9M). The position peaked in Q1 2025 at 446,295 shares, worth US$74.0M. Across 13 filings, EDGAR LOMAX CO/VA increased the stake 3 time(s), trimmed it 9 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 124,530 shares valued at US$33.0M — a reduction of -1,350 shares quarter over quarter.. Notable position changes include a 115% increase in Q1 2024 (shares fell 8% over the following quarter), a 85% increase in Q4 2024 (shares rose 12% over the following quarter), a 49% trim in Q4 2025 (shares rose 18% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 102.29K $15.93M New
Q4 2023 97.87K $15.34M Reduce
Q1 2024 210.47K $33.30M Add
Q2 2024 207.84K $30.38M Reduce
Q3 2024 204.64K $33.16M Reduce
Q4 2024 379.34K $54.86M Add
Q1 2025 446.30K $74.01M Add
Q2 2025 439.12K $67.08M Reduce
Q3 2025 338.12K $62.69M Reduce
Q4 2025 172.00K $35.59M Reduce
Q1 2026 133.54K $32.64M Reduce
Q2 2026 125.88K $31.97M Reduce
Q3 2026 124.53K $32.97M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has EDGAR LOMAX CO/VA held JNJ?

EDGAR LOMAX CO/VA has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is EDGAR LOMAX CO/VA's current position in JNJ?

As of Q3 2026, EDGAR LOMAX CO/VA holds 124.53K shares of JNJ (JOHNSON & JOHNSON), valued at $32.97M, representing 2.49% of its reported portfolio and ranking #15.

Has EDGAR LOMAX CO/VA been buying or selling JNJ?

In the latest 13F filing (Q3 2026), EDGAR LOMAX CO/VA reduced its position in JNJ. The position peaked in Q1 2025 at 446.30K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.